U.S. Entertainment Stock News

NasdaqGS:EVGO
NasdaqGS:EVGOSpecialty Retail

EVgo (EVGO) EPS Loss Narrows To US$0.04 And Tests Bearish Profitability Narratives

EVgo (EVGO) has just opened its Q1 2026 earnings season story with trailing 12 month revenue of about US$384.1 million and a basic EPS loss of US$0.31, setting a clear top line scale against an ongoing bottom line loss. Over recent quarters the company has seen quarterly revenue move from US$67.5 million in Q3 2024 to US$118.5 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.11 to a loss of US$0.04 over the same period. This frames a business that is adding revenue...
NasdaqGS:HSTM
NasdaqGS:HSTMHealthcare Services

HealthStream (HSTM) Margin Compression To 6% Tests Bullish Long Term Growth Narratives

HealthStream (HSTM) sets the stage with steady top line and mixed earnings signals HealthStream (HSTM) has kicked off its Q1 2026 earnings season with a recent track record that shows quarterly revenue ranging from about US$73.5 million to US$79.7 million over 2025, alongside basic EPS between roughly US$0.09 and US$0.21. Over the same period, the company has seen revenue move from US$73.1 million in Q3 2024 to US$79.7 million in Q4 2025. Trailing twelve month EPS has sat between about...
NasdaqGM:EVER
NasdaqGM:EVERInteractive Media and Services

EverQuote (EVER) Net Margin Jump To 14.3% Tests Bullish Profitability Narrative

Q1 2026 results set the tone EverQuote (EVER) has just put fresh numbers on the table, with recent quarterly revenue of about US$195 million and basic EPS of US$1.60 setting the headline for its latest update after a year in which trailing twelve month EPS reached US$2.75 on revenue of roughly US$692.5 million. Over the last few reported quarters, the company has seen revenue move from US$147.5 million in Q4 2024 to US$195.3 million in Q4 2025. Quarterly basic EPS stepped from US$0.35 to...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Paramount Skydance (PSKY) Margin Strain Deepens And Tests Bullish Profitability Narratives

Paramount Skydance (PSKY) has opened Q1 2026 earnings season with recent quarterly revenue in the range of about US$6.7b to US$8.1b and EPS swinging between a profit of US$0.23 and a loss of US$0.52 over the last four reported quarters, setting a cautious backdrop for investors focused on profitability. Over that period, the company has seen revenue move from US$7.2b in Q1 2025 to US$8.1b in Q4 2025, while basic EPS shifted from US$0.23 in Q1 2025 to a loss of US$0.52 in Q4 2025, reflecting...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

A Look At Expand Energy (EXE) Valuation After Earnings Recovery And Ongoing Shareholder Returns

Q1 earnings, dividend and buyback activity Expand Energy (EXE) recently reported first quarter 2026 results, with revenue of US$4,397 million and net income of US$1,159 million, alongside a return to positive earnings per share from continuing operations. The company also affirmed a quarterly base dividend of US$0.575 per share, scheduled for June 4, 2026, and completed a share repurchase tranche covering 0.99% of its stock since late 2024. See our latest analysis for Expand Energy. EXE's...
NasdaqGS:BKNG
NasdaqGS:BKNGHospitality

Is It Time To Reassess Booking Holdings (BKNG) After This Year’s Share Price Slide

If you are wondering whether Booking Holdings is starting to look attractively priced, the recent share performance gives you a lot to think about. The stock closed at US$167.63, with returns of 3.3% decline over 7 days, 0.1% decline over 30 days, 21.3% decline year to date and 18.2% decline over 1 year, set against longer term returns of 62.0% over 3 years and 89.9% over 5 years. Recent coverage has focused on Booking Holdings in the context of broader travel and online booking trends, as...
NYSE:CRD.B
NYSE:CRD.BInsurance

Crawford (CRD.B) Margin Hits 1.6% Challenging Bullish Profit Expansion Narratives

Latest Results Snapshot Crawford (CRD.B) has kicked off Q1 2026 reporting season with recent figures that show quarterly revenue moving between US$308.5 million and US$347.3 million over the past six reported periods, while basic EPS has ranged from a loss of US$0.15 to a profit of US$0.25 per share. Trailing twelve month EPS most recently stood at US$0.40 on net income of US$19.6 million. The company has seen revenue shift from US$347.3 million in Q4 2024 to US$308.5 million in Q4 2025, with...
NYSE:AMP
NYSE:AMPCapital Markets

How Investors Are Reacting To Ameriprise Financial (AMP) Stronger Earnings And A 6% Dividend Increase

Ameriprise Financial, Inc. has already reported first-quarter 2026 results, with revenue rising to US$4,886 million and net income to US$915 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. On the same day, the board approved a 6% increase in the regular quarterly dividend to US$1.70 per share and completed a meaningful portion of its ongoing share repurchase program, highlighting continued emphasis on shareholder...
NYSE:PEG
NYSE:PEGIntegrated Utilities

Public Service Enterprise Group (PEG) Earnings Growth Slowdown Tests Bullish Narratives

Public Service Enterprise Group (PEG) has just wrapped up Q1 2026 with investors looking back at a run of recent results that include Q4 2025 revenue of US$2,915 million, basic EPS of US$0.63 and trailing 12 month EPS of US$4.23 on revenue of US$12.2 billion, backed by 19.1% earnings growth over the past year. Over recent quarters, revenue has ranged from US$2,642 million to US$3,226 million while quarterly EPS has moved between US$0.57 and US$1.25. This sets the backdrop for trailing net...
NYSE:KOS
NYSE:KOSOil and Gas

Kosmos Energy (KOS) Deep Q4 EPS Loss Tests Bullish Margin Recovery Narrative

Kosmos Energy (KOS) opened Q1 2026 with recent quarterly revenue of US$294.9 million and a basic EPS loss of US$0.79 in Q4 2025, alongside net income excluding extra items of a US$377.1 million loss. Over the prior quarters, the company reported revenue of US$407.8 million in Q3 2024, US$392.9 million in Q2 2025, and US$311.2 million in Q3 2025, while basic EPS moved from a profit of US$0.10 in Q3 2024 to a loss of US$0.26 in Q3 2025. For investors, the latest print keeps attention on how...
NYSE:CMI
NYSE:CMIMachinery

Cummins (CMI) Margin Compression Tests Bullish Growth Narratives Heading Into Q1 2026

Q1 2026 earnings snapshot Cummins (CMI) has kicked off 2026 with Q1 results that follow a year where trailing 12 month revenue sat at US$33.7b and Basic EPS was US$20.62, alongside a net income of US$2.8b. Over the last six reported quarters, revenue has ranged from US$8.2b to US$8.6b per quarter while Basic EPS moved between US$3.04 and US$6.46, giving investors a clear view of how earnings track against a relatively tight revenue band. With margins that recently eased from prior levels, the...
NYSE:HESM
NYSE:HESMOil and Gas

Hess Midstream (HESM) Margin Expansion To 21.8% Reinforces Bullish Earnings Narratives

Hess Midstream (HESM) opened 2026 earnings season with Q1 results that sit against a backdrop of 2025 revenue between US$382 million and US$420.9 million per quarter and basic EPS ranging from US$0.65 to US$0.75, with trailing 12 month revenue at US$1.62 billion and basic EPS of US$2.87. Over the last year, revenue has moved from US$378.5 million in Q3 2024 to US$404.2 million in Q4 2025, while basic EPS has shifted from US$0.63 to US$0.72, giving investors a clear view of how both the top...
NYSE:BCC
NYSE:BCCTrade Distributors

Boise Cascade (BCC) Margin Compression To 2.1% Tests Bullish Efficiency Narrative

Boise Cascade (BCC) has just reported its Q1 2026 results against a backdrop where recent quarters showed Q4 2025 revenue of about US$1.5b and basic EPS of roughly US$0.24, alongside trailing 12 month revenue of about US$6.4b and basic EPS of US$3.54. Over the past six reported quarters, revenue has ranged from roughly US$1.5b to US$1.7b while quarterly EPS has moved between about US$0.24 and US$2.34. This sets up the latest update as a check in on how margins are holding up across the...
NYSE:AVB
NYSE:AVBResidential REITs

What AvalonBay Communities (AVB)'s Strong Q1 Results, EPS Guidance and Buybacks Mean For Shareholders

AvalonBay Communities, Inc. recently reported past first-quarter 2026 results showing higher revenue of US$770.28 million and net income of US$325.73 million, issued new EPS guidance for the second quarter and full year 2026, completed US$500 million in share repurchases across two authorizations, and filed a US$40 million ESOP-related common stock shelf registration. This combination of stronger earnings, fresh guidance, and active capital management highlights how AvalonBay is balancing...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

Is It Time To Reassess ICON (ICLR) After Recent Share Price Volatility?

If you are wondering whether ICON's current share price reflects its underlying value, the recent moves in the stock give you a timely reason to take a closer look. The stock recently closed at US$121.32, with returns of 18.4% over 7 days and 6.2% over 30 days, set against a year-to-date return of a 35.7% decline and a 10.2% decline over the past year. These price moves have come as ICON continues to attract attention in the contract research and life sciences outsourcing space, where...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

BWX Technologies (BWXT) Earnings Growth And 10.3% Margin Test Rich Valuation Narrative

BWX Technologies (BWXT) has just wrapped up Q1 2026 with investors looking closely at how the recent revenue and EPS trajectory sets the tone for the new year, particularly after trailing 12 month net income of US$328.9 million and basic EPS of US$3.59 against a current share price of US$206.15. Over the last six reported quarters, revenue has moved from US$671.9 million in Q3 2024 to US$885.8 million in Q4 2025, while quarterly basic EPS has ranged from US$0.76 to US$1.02, giving investors a...
NasdaqGS:CATY
NasdaqGS:CATYBanks

Stronger Q1 Earnings And New Buyback Plan Might Change The Case For Investing In Cathay General Bancorp (CATY)

Cathay General Bancorp reported first-quarter 2026 results, with net interest income rising to US$194.17 million and net income reaching US$86.89 million, alongside higher earnings per share versus a year earlier. On the same day, the company disclosed it had completed a US$150.00 million buyback program and announced a new share repurchase authorization of up to US$150.00 million, underscoring continued capital returns alongside earnings growth. With stronger quarterly earnings and a fresh...
NYSE:MAIN
NYSE:MAINCapital Markets

Is It Too Late To Consider Main Street Capital (MAIN) After Recent Share Price Recovery?

For investors wondering whether Main Street Capital is attractively priced today or if the easier gains are already behind it, this breakdown focuses on what you are paying versus what you may be getting. The stock last closed at US$57.36, with returns of 5.0% over the past week, 9.0% over the past month, a year-to-date decline of 7.1%, and gains of 16.4% over 1 year, 79.7% over 3 years, and 106.8% over 5 years. Recent coverage of Main Street Capital has focused on its position within the...
NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

Assessing MKS Instruments (MKSI) Valuation After A Powerful Yearlong Share Price Run

Why MKS Stock Is On Investors’ Radar MKS (MKSI) has been drawing attention after a strong run over the past year, with the stock’s recent price of $287.65 sitting against a backdrop of multi segment semiconductor exposure. See our latest analysis for MKS. The recent pullback in the share price over the last day contrasts with a strong run, with a 30 day share price return of 22.6% and a 1 year total shareholder return of very close to 300%. This suggests that momentum has been building rather...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Is Catalyst Pharmaceuticals (CPRX) Share Price Rally Still Supported By Cash Flow Outlook?

If you are wondering whether Catalyst Pharmaceuticals' recent share price puts it at a bargain or a stretch, the following sections break that question down into clear valuation checks. The stock last closed at US$30.86, with returns of 4.8% over the past week, 25.0% over the past month, 33.3% year to date and 33.8% over the past year, which raises questions about how that performance lines up with underlying value. Recent headlines around Catalyst Pharmaceuticals have focused on its...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab’s Taiwan Move And Indonesia Rules Prompt Fresh Look At GRAB

Grab Holdings (NasdaqGS:GRAB) has agreed to acquire Delivery Hero’s foodpanda business in Taiwan, marking its first major move beyond Southeast Asia. The deal extends Grab’s delivery footprint into a new market where it has not previously operated. Indonesia has introduced a new regulatory cap on ride hailing commissions, cutting the maximum rate from 20% to 8% and adding new social protections for drivers. These regulatory changes directly affect Grab’s largest regional market and could...
NYSE:BKSY
NYSE:BKSYProfessional Services

Is It Too Late To Consider Buying BlackSky Technology (BKSY) After Its 321% One Year Surge?

If you are wondering whether BlackSky Technology's current share price reflects its true worth, the recent performance gives plenty to think about. The stock last closed at US$35.96, with returns of 15.2% over 7 days, 16.7% over 30 days, 72.7% year to date, 321.1% over 1 year and 284.2% over 3 years, while the 5 year return sits at a 54.6% decline. Recent price action has drawn attention to BlackSky Technology, with investors focusing on how current expectations align with the stock's past...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin Pharmaceutical (BMRN) Margin Compression Challenges Bullish Earnings Narratives

BioMarin Pharmaceutical (BMRN) opened 2026 with Q1 results that build on a run of quarterly revenue between US$745.1 million and US$874.6 million over 2025, while EPS has swung from a profit of US$1.25 in Q2 2025 to a loss of US$0.24 in Q4 2025 as one off items fed into the reported figures. Over the last six reported quarters, revenue has ranged from about US$745.1 million to US$874.6 million and trailing 12 month EPS has moved between US$1.70 and US$3.44. This gives you a clear view of how...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Q1 Loss Widening To US$64.5 Million Tests Profitability Narratives

Axsome Therapeutics (AXSM) Q1 2026 earnings snapshot Axsome Therapeutics (AXSM) has opened 2026 with Q1 revenue of US$191.2 million and a basic EPS loss of US$1.26, alongside a net loss of US$64.5 million, setting a clear benchmark for how the rest of the year might look. The company has seen revenue progress from US$118.8 million in Q4 2024 to US$191.2 million in Q1 2026, while trailing twelve month EPS has moved from a loss of US$5.99 to a loss of US$3.74 as revenue reached US$708.2 million...